While we are waiting for the IND approval by the FDA, it's worth appreciating who we have guiding PYC.
In January the Galien foundation appointed Dr Rosenblatt (a director on PYC's board) as chairman of Prix Galien USA awards committee. In gaining this position, it shows the esteem and standing Dr Rosenblatt is held in academia and industry.
Check out the link:
https://www.prnewswire.com/news-releases/the-galien-foundation-appoints-michael-rosenblatt-md-as-chairman-of-prix-galien-usa-awards-committee-301714290.html
Ann: PYC Corporate Presentation - February 2023, page-16
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
-0.005(4.00%) |
Mkt cap ! $559.9M | |||
| Open | High | Low | Value | Volume |
| 12.3¢ | 12.5¢ | 11.8¢ | $108.1K | 901.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 1170950 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 31 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2024 (20 minute delay) ? |
| PYC (ASX) Chart |